You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Libtayo

Showing 1 - 25 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Buderim, Adelaide (6-Thio-2'-Deoxyguanosine, Cemiplimab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Buderim, Queensland, Australia
  • +1 more
Jul 5, 2022

NSCLC Trial (Dupilumab, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Dupilumab
  • Cemiplimab
  • (no location specified)
Oct 12, 2023

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)

Recruiting
  • Hormone Receptor-positive Breast Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Dec 30, 2022

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +3 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
May 17, 2023

Basal Cell Carcinoma Trial in Zürich (Cemiplimab Injection [Libtayo])

Recruiting
  • Basal Cell Carcinoma
  • Cemiplimab Injection [Libtayo]
  • Zürich, Switzerland
    University Hospital Zurich, Clinic of Dermatology
Nov 3, 2022

Cemiplimab to Historical Standard of Care in France

Recruiting
  • Cancer/Squamous Cell Carcinoma of Skin
  • France, France
    (unnamed)
Jun 6, 2022

Glioblastoma Trial in United States (Ad-RTS-hIL-12, Veledimex, Cemiplimab-Rwlc)

Completed
  • Glioblastoma
  • Ad-RTS-hIL-12
  • +2 more
  • Los Angeles, California
  • +6 more
Nov 3, 2021

Melanoma Trial in Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Dec 20, 2022

Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)

Active, not recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +3 more
Jan 13, 2023

Advanced NSCLC Trial (fianlimab, cemiplimab, Placebo)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Mar 27, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 5, 2022

NSCLC Trial (fianlimab, cemiplimab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Mar 23, 2023

Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

Recruiting
  • Secondary Angiosarcoma
  • +2 more
  • Nijmegen, Netherlands
    RadboudUMC
Jan 19, 2022

Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck Trial in Tucson, Tampa

Terminated
Has Results
  • Cutaneous Squamous Cell Carcinoma
  • Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • Tucson, Arizona
  • +1 more
Nov 2, 2022

Advanced NSCLC Trial (BNT116, Cemiplimab)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jan 3, 2023

Mycosis Fungoides Trial in Edmonton (Cemiplimab)

Not yet recruiting
  • Mycosis Fungoides
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Sep 12, 2022

Locally Advanced Basal Cell Carcinoma Trial in Philadelphia (biological, procedure, other)

Not yet recruiting
  • Locally Advanced Basal Cell Carcinoma
  • Cemiplimab
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jun 28, 2023

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Melanoma Trial in Orlando, Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Orlando, Florida
  • +1 more
Jul 5, 2022

Tumor Trial in Quebec (SAR444200, Cemiplimab)

Recruiting
  • Neoplasm
  • SAR444200
  • Cemiplimab
  • Providence, Rhode Island
  • +3 more
Oct 17, 2022

Recurrent Skin Squamous Cell Carcinoma, Resectable Skin Squamous Cell Carcinoma, Stage I Skin Cancer Trial in Los Angeles,

Recruiting
  • Recurrent Skin Squamous Cell Carcinoma
  • +4 more
  • Cemiplimab
  • Resection
  • Los Angeles, California
  • +2 more
Nov 12, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
May 1, 2023